The March IPO market is set to start off with a quiet week. One sizable issuer is scheduled to list, though other smaller names may join the calendar late.Medical device firm Kestra Medical Technologies (KMTS) plans to raise $150 million at a $716 million...read more
Some small IPOs are tentatively scheduled for the short holiday week ahead.Dubai-based robotics developer Micropolis Holdings (MCRP) plans to raise $23 million at a $158 million market cap. Micropolis specializes in autonomous mobile robots that utilize...read more
Apimeds Pharmaceuticals US, a clinical stage biotech developing bee venom-based treatment for inflammation, raised the proposed deal size for its upcoming IPO on Wednesday.The Hopewell, NJ-based company now plans to raise $20 million by offering 4.5 million...read more
US IPO Week Ahead: Small IPOs may list amid market volatility
...read more
US IPO Week Ahead: Medical device maker lines up the first sizable March IPO
The March IPO market is set to start off with a quiet week. One sizable issuer is scheduled to list, though other smaller names may join the calendar late.Medical device firm Kestra Medical Technologies (KMTS) plans to raise $150 million at a $716 million...read more
US IPO Week Ahead: Small IPOs tentatively scheduled for the short holiday week
Some small IPOs are tentatively scheduled for the short holiday week ahead.Dubai-based robotics developer Micropolis Holdings (MCRP) plans to raise $23 million at a $158 million market cap. Micropolis specializes in autonomous mobile robots that utilize...read more
Inflammation biotech Apimeds Pharmaceuticals ups deal size by 74% ahead of $20 million IPO
Apimeds Pharmaceuticals US, a clinical stage biotech developing bee venom-based treatment for inflammation, raised the proposed deal size for its upcoming IPO on Wednesday.The Hopewell, NJ-based company now plans to raise $20 million by offering 4.5 million...read more